FIELD: chemistry; pharmaceuticals; medicine.
SUBSTANCE: group of inventions relates to a new chemical compound, a derivative of N4-hydroxycytidine which can be used to inhibit the replication of RNA and DNA-containing viruses (coronavirus, arbovirus and orthoreovirus). A group of inventions relates to the field of organic chemistry and pharmaceuticals, namely to a new derivative of N4-hydroxycytidine, which can be used to inhibit the replication of RNA and DNA-containing viruses. A compound is disclosed, which is a derivative of N4-hydroxycytidine of the presented formula or a pharmaceutically acceptable salt thereof. Also the use of the above compound or a pharmaceutically acceptable salt thereof for inhibiting the replication of an RNA or DNA-containing virus is disclosed.
EFFECT: effective inhibition of RNA or DNA-containing virus replication.
6 cl, 6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE | 2022 |
|
RU2791916C1 |
| 5'-O-(4-PHENYLBUTANOYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817201C1 |
| 5'-O-(4-CHLOROPHENOXYACETYL)-N4-HYDROXYCYTIDINE AND USE THEREOF | 2023 |
|
RU2817609C1 |
| USE OF 5'-O-(3-PHENYLPROPIONYL)-N4-HYDROXYCYTIDINE TO INHIBIT INFLUENZA VIRUS REPLICATION IN VITRO AND IN VIVO | 2022 |
|
RU2791806C1 |
| MODIFIED ANTISENSE OLIGONUCLEOTIDE AGAINST SARS-CoV-2 | 2020 |
|
RU2750584C1 |
| URACIL DERIVATIVES WITH ANTIVIRAL ACTIVITY AGAINST SARS-COV-2 | 2021 |
|
RU2769828C1 |
| AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
| APPLICATION OF A DERIVATIVE OF 1,3,5-TRIAZINE-2,4-DIAMINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780249C1 |
| APPLICATION OF AN OXYGEN-CONTAINING DERIVATIVE OF 6-HALOQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2, AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2780245C1 |
| USE OF ALCOHOLIC EXTRACT OF AERIAL PARTS OF MARAL ROOT RHAPONTICUM CARTHAMOIDES AS AGENT, INHIBITING ACTIVITY OF CORONAVIRUS SARS-CoV-2 AND HERPES SIMPLEX VIRUS TYPE 2 IN VITRO AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2825393C1 |
